Ultragenyx Pharmaceutical Inc at Bank of America Merrill Lynch Health Care Conference Transcript
Good afternoon, everybody. Thanks for joining us at the Bank of America Merrill Lynch Healthcare conference. I'm Tazeen Ahmad. I am the Senior (inaudible) biotech analyst here at BAML. It's my pleasure to present the next company at our conference, Ultragenyx Pharmaceuticals. Presenting for Ultragenyx today, to my right is Shalini Sharp, Chief Financial Officer. Shalini, thanks for joining us. And Shalini's going to give you a quick introduction to Ultragenyx with a few slides, and then we'll switch over to Q&A. And if anyone in the audience has a question at any time, just raise your hand and we can take your question. So, with that, I'll turn it over to you, Shalini.
Thank you. Thank you to Bank of America, and to you for hosting us today, and to everyone who came to watch. I'll just speak for a couple minutes, and then we'll have a conversation.
So just a little bit of background on Ultragenyx. We are now 9 years old,
| Access to All Earning Calls and Stock Analysis | |
| 30-Year Financial on one screen | |
| All-in-one Stock Screener with unlimited filters | |
| Customizable Stock Dashboard | |
| Real Time Insider Trading Transactions | |
| 8,000+ Institutional investors’ 13F holdings | |
| Powerful Excel Add-in and Google sheets Add-on | |
| All data downloadable | |
| Quick customer support | |
| And much more... |
Trustpilot
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
